TenX Keane Acquisition Unit
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch TENKU and buy or sell other stocks, ETFs, and their options commission-free!About TENKU
Citius Oncology, Inc. is a biopharmaceutical company, which engages in developing and commercializing targeted oncology therapies. Its lead product candidate is LYMPHIR, an engineered IL-2 diphtheria toxin fusion protein, for the treatment of patients with persistent or recurrent CTCL, a rare form of non-Hodgkin lymphoma.
CEOLeonard L. Mazur, MBA
CEOLeonard L. Mazur, MBA
Employees—
Employees—
HeadquartersCranford, New Jersey
HeadquartersCranford, New Jersey
Founded
Founded
Employees—
Employees—
TENKU Key Statistics
Market cap3.73B
Market cap3.73B
Price-Earnings ratio-231.09
Price-Earnings ratio-231.09
Dividend yield—
Dividend yield—
Average volume—
Average volume—
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$45.84
52 Week high$45.84
52 Week low$11.32
52 Week low$11.32
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.